Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guidalberto Manfioletti

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Oncotarget|August 13, 2015
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressivenessSilvia Pegoraro, Gloria Ros, Yari Ciani, et al.
Expert Opinion on Therapeutic Targets|May 31, 2022
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targetsAlberto Zambelli, Riccardo Sgarra, Rita De Sanctis, et al.
Journal of Proteome Research|March 26, 2009
Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding propertiesRiccardo Sgarra, Elisa Maurizio, Salvina Zammitti, et al.
The Journal of Cell Biology|July 13, 2006
Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transitionSylvie Thuault, Ulrich Valcourt, Maj Petersen, et al.
Biochemistry|January 23, 2002
A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genesAlessandra Rustighi, Michela A Tessari, Fulvia Vascotto, et al.
Plos One|January 18, 2013
Identification and characterization of new molecular partners for the protein arginine methyltransferase 6 (PRMT6)Alessandra Lo Sardo, Sandro Altamura, Silvia Pegoraro, et al.
Human Pathology|September 4, 2012
The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasivenessClaudio Rizzi, Palmina Cataldi, Aldo Iop, et al.
Nucleic Acids Research|February 28, 2007
The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and functionGiacomo Cattaruzzi, Sandro Altamura, Michela A Tessari, et al.
Expert Opinion on Therapeutic Targets|September 24, 2020
Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategiesSilvia Pegoraro, Gloria Ros, Michela Sgubin, et al.
International Journal of Molecular Sciences|August 29, 2024
Binding to the Other Side: The AT-Hook DNA-Binding Domain Allows Nuclear Factors to Exploit the DNA Minor GrooveSabrina Battista, Monica Fedele, Luca Secco, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Oncotarget|August 13, 2015
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressivenessSilvia Pegoraro, Gloria Ros, Yari Ciani, et al.
Expert Opinion on Therapeutic Targets|May 31, 2022
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targetsAlberto Zambelli, Riccardo Sgarra, Rita De Sanctis, et al.
Journal of Proteome Research|March 26, 2009
Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding propertiesRiccardo Sgarra, Elisa Maurizio, Salvina Zammitti, et al.
The Journal of Cell Biology|July 13, 2006
Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transitionSylvie Thuault, Ulrich Valcourt, Maj Petersen, et al.
Biochemistry|January 23, 2002
A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genesAlessandra Rustighi, Michela A Tessari, Fulvia Vascotto, et al.
Plos One|January 18, 2013
Identification and characterization of new molecular partners for the protein arginine methyltransferase 6 (PRMT6)Alessandra Lo Sardo, Sandro Altamura, Silvia Pegoraro, et al.
Human Pathology|September 4, 2012
The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasivenessClaudio Rizzi, Palmina Cataldi, Aldo Iop, et al.
Nucleic Acids Research|February 28, 2007
The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and functionGiacomo Cattaruzzi, Sandro Altamura, Michela A Tessari, et al.
Expert Opinion on Therapeutic Targets|September 24, 2020
Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategiesSilvia Pegoraro, Gloria Ros, Michela Sgubin, et al.
International Journal of Molecular Sciences|August 29, 2024
Binding to the Other Side: The AT-Hook DNA-Binding Domain Allows Nuclear Factors to Exploit the DNA Minor GrooveSabrina Battista, Monica Fedele, Luca Secco, et al.
Pageof 7